Congenital hyperinsulinism is rare; most children's hospitals encounter only one or two cases a year. Since October 1998 the Congenital Hyperinsulinism Center at The Children's Hospital of Philadelphia has evaluated and treated more than 400 patients — making it the largest program of its kind in North America.
Providing full services for congenital hyperinsulinism requires sophisticated multidisciplinary team capabilities. Our Center includes a team of specialists in endocrinology, pediatric surgery, pathology and interventional radiology who have long experience in treating infants with this condition.
In addition, CHOP has a nationally top-ranked newborn/infant intensive care unit, allowing us to provide seamless care for children with complex conditions.
Diva D. De León Crutchlow, MD, is the Medical Director of the Division of Endocrinology and Diabetes at The Children's Hospital of Philadelphia and Assistant Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Read more »
Reach an International Care Coordinator at:
Doctors in Australia discovered Lachlan’s low blood sugar when he was only 3 days old. Eventually, he was diagnosed with HI, a condition caused by lesions in the pancreas that disrupt its normal production of insulin. Read Lachlan's story »